当前位置: 首页 > 详情页

Hydrogen sulfide inhibits the renal fibrosis of obstructive nephropathy

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Institute of Neuroscience, Soochow University, Suzhou, China [2]Department of Nephrology, Second Affiliated Hospital of Soochow University, Suzhou, China [3]Department of Chemistry and Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, Georgia, USA [4]Department of Neurology, Second Affiliated Hospital of Soochow University, Suzhou, China [5]Department of Pharmacology, School of Pharmaceutical Science, Soochow University, Suzhou, China
出处:
ISSN:

关键词: cell signaling chronic inflammation chronic renal disease

摘要:
Hydrogen sulfide has recently been found decreased in chronic kidney disease. Here we determined the effect and underlying mechanisms of hydrogen sulfide on a rat model of unilateral ureteral obstruction. Compared with normal rats, obstructive injury decreased the plasma hydrogen sulfide level. Cystathionine-beta-synthase, a hydrogen sulfide producing enzyme, was dramatically reduced in the ureteral obstructed kidney, but another enzyme cystathionine-gamma-lyase was increased. A hydrogen sulfide donor (sodium hydrogen sulfide) inhibited renal fibrosis by attenuating the production of collagen, extracellular matrix, and the expression of a-smooth muscle actin. Meanwhile, the infiltration of macrophages and the expression of inflammatory cytokines including interleukin-1 beta, tumor necrosis factor-alpha, and monocyte chemoattractant protein-1 in the kidney were also decreased. In cultured kidney fibroblasts, a hydrogen sulfide donor inhibited the cell proliferation by reducing DNA synthesis and downregulating the expressions of proliferation-related proteins including proliferating cell nuclear antigen and c-Myc. Further, the hydrogen sulfide donor blocked the differentiation of quiescent renal fibroblasts to myofibroblasts by inhibiting the transforming growth factor-beta 1-Smad and mitogen-activated protein kinase signaling pathways. Thus, low doses of hydrogen sulfide or its releasing compounds may have therapeutic potentials in treating chronic kidney disease.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
大类 | 1 区 医学
小类 | 1 区 泌尿学与肾脏学
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 泌尿学与肾脏学
JCR分区:
出版当年[2012]版:
Q1 UROLOGY & NEPHROLOGY
最新[2023]版:
Q1 UROLOGY & NEPHROLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2012版] 出版当年五年平均 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者机构: [1]Institute of Neuroscience, Soochow University, Suzhou, China [2]Department of Nephrology, Second Affiliated Hospital of Soochow University, Suzhou, China
共同第一作者:
通讯作者:
通讯机构: [*1]Department of Neurology, Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou 215004, China. [*2]Institute of Neuroscience, Soochow University, 199 Ren-Ai Road, Suzhou Industrial Park, Suzhou 215123, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院